• OPEN AN ACCOUNT
Indian Indices
Sensex
73,852.90 -876.37
( -1.17%)
Global Indices
Nasdaq
51,986.54 -36.87
(-0.07%)
Dow Jones
7,712.39 31.95
(0.42%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,765.28 -116.62
(-1.07%)
Forex
USD-INR
94.77 -0.08
(-0.08%)
EUR-INR
106.47 0.12
(0.11%)
GBP-INR
126.26 0.54
(0.43%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3529756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
35.47
2939.37
EPS(TTM)
Face Value()
Div & Yield %
7.4
2
2.04
 

B&B Triplewall Containers reports consolidated net profit of Rs 9.09 crore in the March 2026 quarter
Jun 01,2026
Net profit of B&B Triplewall Containers reported to Rs 9.09 crore in the quarter ended March 2026 as against net loss of Rs 1.83 crore during the previous quarter ended March 2025. Sales rose 14.67% to Rs 162.34 crore in the quarter ended March 2026 as against Rs 141.57 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 20.64 crore in the year ended March 2026 as against net loss of Rs 5.53 crore during the previous year ended March 2025. Sales rose 25.34% to Rs 616.35 crore in the year ended March 2026 as against Rs 491.76 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales162.34141.57 15 616.35491.76 25
OPM %17.4311.17 -14.698.13 -
PBDT23.5910.36 128 69.0823.30 196
PBT11.51-2.68 LP 26.46-7.83 LP
NP9.09-1.83 LP 20.64-5.53 LP